Jiyan Liu
Clinical trials sponsored by Jiyan Liu, explained in plain language.
-
New vaccine aims to cure chronic hepatitis b in early trial
⭐️ VACCINE ⭐️ Recruiting nowThis early-stage trial tests a new vaccine called WGc0201 in 9 adults with chronic hepatitis B who are already on standard antiviral therapy. The vaccine is designed to boost the immune system to clear the virus, potentially leading to a functional cure. The main goal is to check…
Phase: PHASE1 • Sponsor: Jiyan Liu • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 03, 2026 00:00 UTC
-
Promising drug cocktail aims to shrink penile cancer before surgery
Disease control Recruiting nowThis phase II trial tests a combination of two drugs—Becotatug vedotin (a targeted therapy that attacks cancer cells with a specific protein) and Pucotenlimab (an immunotherapy that boosts the immune system)—in men with advanced penile cancer that is hard to treat with surgery al…
Phase: PHASE2 • Sponsor: Jiyan Liu • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New hope for rare penile cancer: targeted drug combo shows promise
Disease control Recruiting nowThis early-phase trial tests a new two-drug combination (MRG003 and HX008) as a first treatment for advanced penile cancer that has spread. It aims to be more effective and less toxic than standard chemotherapy. The study enrolls 10 men with a specific type of cancer (EGFR-positi…
Phase: PHASE1 • Sponsor: Jiyan Liu • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC